Sponsored by: Fujifilm

MRI: Page 202

FDA issues directive on GBCA labeling, safety research
By Wayne Forrest
The U.S. Food and Drug Administration (FDA) on Tuesday issued a directive requiring that manufacturers of gadolinium-based contrast agents (GBCAs) add a new warning to their product labeling that notifies healthcare providers that patients could retain gadolinium long after an MRI scan.
December 18, 2017
2016 10 04 14 10 28 621 Gadolinium 400
X-ray fluorescence detects retained gadolinium in bone
By Wayne Forrest
As the safety of gadolinium MRI contrast is hotly debated, one of the challenges has been detecting gadolinium deposition in living patients. Canadian researchers may have found a solution to the dilemma with an x-ray fluorescence system that can noninvasively detect trace elements of gadolinium in exposed individuals.
December 18, 2017
2016 10 04 14 10 28 621 Gadolinium 400
MRI contrast agent could aid inflammation imaging
By AuntMinnie.com staff writers
Researchers from Binghamton University in Binghamton, NY, and Temple University in Philadelphia are developing a nanoparticle-based MRI contrast agent that could help physicians visualize areas of inflammation.
December 13, 2017
MRI confirms prostate cancer with lower dose of GBCA
By Wayne Forrest
MRI scans with a reduced dose of a gadolinium-based contrast agent (GBCA) can be more effective than scans with a standard dose in differentiating between malignant and benign lesions in prostate cancer patients, according to a study presented recently at RSNA 2017.
December 13, 2017
2017 06 15 10 31 55 42 Prostate 400
Smart Choice MRI closes orthopedic clinic deal
By AuntMinnie.com staff writers
Smart Choice MRI is partnering with Barrington Orthopedic Specialists, a large orthopedic group with four clinics in the Chicago suburbs.
December 11, 2017
fMRI, PET could help foresee epileptic seizure issues
By Wayne Forrest
Researchers have developed a method to integrate functional MR (fMRI) and PET images to identify epilepsy patients who are at high risk of continued seizures before the patients undergo potentially unsuccessful surgery, according to a study published online December 5 in Frontiers in Neuroscience.
December 11, 2017
2016 08 26 09 42 23 633 Brain Headache 400
SABCS: Biannual breast MRI best for young women at high risk
By Kate Madden Yee
For young women with a high genetic risk of breast cancer, twice-yearly MRI exams are more effective for detecting early disease than an annual mammogram, according to new research presented at the 2017 San Antonio Breast Cancer Symposium (SABCS).
December 10, 2017
2016 10 05 17 45 45 493 Breast Cancer 400
PET/MRI outclasses MRI alone for pelvic cancer recurrence
By Wayne Forrest
PET/MRI can better detect and classify local lesions and distant metastases in women suspected of having recurrent pelvic cancer than MRI alone, according to a study presented at the recent RSNA 2017 annual meeting.
December 10, 2017
2017 12 08 18 29 3110 2017 12 11 Sawiki Pet Mri Pelvic 20171208181055
At-risk women not receiving breast MRI scans
By Kate Madden Yee
Community practices are not following guidelines for breast cancer screening with MRI in women at increased risk of the disease, according to a new study published online December 7 in the Journal of General Internal Medicine.
December 7, 2017
2016 08 18 13 26 22 430 Breast Screening Mammo 400
Japan requires changes in GBCA labeling information
By Wayne Forrest
Japan's Ministry of Health, Labor, and Welfare is following suit with regulatory agencies in the U.S. and Europe in asking four makers of gadolinium-based contrast agents (GBCAs) for MRI scans to revise warning text on their product labeling information.
December 7, 2017
2017 05 26 14 17 18 219 Gadolinium2 400
Brainlab gets FDA nod for MR contrast analysis software
By AuntMinnie.com staff writers
Image-guided therapy firm Brainlab has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Contrast Clearance Analysis software.
December 5, 2017
IMRIS, Hill-Rom get FDA nod for operating room table
By AuntMinnie.com staff writers
Image-guided therapy developer IMRIS and Hill-Rom's Trumpf Medical company have received U.S. Food and Drug Administration (FDA) clearance for the TruSystem 7500 MR neuro surgical table, a multifunctional operating room table.
December 4, 2017
Previous Page
Page 202 of 624
Next Page